Dynamic changes of CTCs in patients with metastatic HR(+)/HER2(-) breast cancer receiving salvage treatment with everolimus/exemestane.

Maria SpiliotakiGalatea KallergiChristos NikolaouNikolaos XenidisEleni PolitakiStella ApostolakiNefeli GeorgouliaFilippos KoinisNikolaos TsoukalasDora HatzidakiAthanasios KotsakisVassilis Georgoulias

Published in: Cancer chemotherapy and pharmacology (2021)

The combination of E/E resulted in early elimination of proliferating CTCs in mBC patients and this effect was associated with a favorable clinical outcome.

Keyphrases

end stage renal disease
circulating tumor cells
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
patient reported outcomes
patient reported